Financial

Nasdaq Grants Windtree Therapeutics 180-day Extension to Regain Compliance

WARRINGTON, Pa., Dec. 05, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today announced that the NASDAQ Stock Market (“Nasdaq”) has granted Windtree an additional 180 days to regain compliance with Nasdaq’s $1.00 […]

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CARLSBAD, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on December 1, 2022 that were approved by the Compensation Committee of its Board of […]

Rocket Pharmaceuticals Completes Acquisition of Renovacor

Acquisition further extends Rocket’s leadership in AAV-based cardiac gene therapy and expands focus and capabilities to BAG3-associated dilated cardiomyopathy CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces that […]

Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board

HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins its Board of Directors as a permanent guest. Dr. Vardeny is an Associate professor of Medicine at the University of Minnesota Medical School, with […]

Broadview Ventures Appoints Michael Mendelsohn, MD to its Strategic Advisory Board

BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced the appointment of Michael E. Mendelsohn, MD to its Strategic Advisory Board.  Dr. Mendelsohn is an internationally recognized cardiovascular physician-scientist, industry research leader and biopharma executive with four decades of broad healthcare and medical experience. Dr. Mendelsohn is […]

T-Heart Appoints Sarah Sorrel as Independent Board Member

PARIS–(BUSINESS WIRE)–T-Heart, a medtech company developing a truly novel and differentiated transcatheter tricuspid prosthetic heart valve specifically designed for tricuspid regurgitation, today announced it has appointed Sarah Sorrel as its first independent member of the Board of Directors. Sarah Sorrel has more than 30 years’ experience in medical device regulation […]

Dr. Sean Lyden Agrees to Assume the Role of Chief Medical Consultant and Join the VESTECK Scientific Advisory Board

WEST CHESTER, Pa., Nov. 28, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce that, Dr. Sean Lyden has agreed to assume the role of Chief Medical Consultant and also join the VESTECK Scientific Advisory Board. Dr. Lyden is currently the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold […]

Viz.ai Appoints Radiology Advisory Board to Advance Innovation

Leading experts to help shape the future of Viz.ai’s radiology strategy and platform SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support radiologists and patients. […]